Echinocandins: a new class of antifungal

被引：221

作者：

Denning, DW

机构：

[1] Wythenshawe Hosp, Educ & Res Ctr, Manchester M23 9LT, Lancs, England

[2] Univ Manchester, Manchester M13 9PL, Lancs, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 49卷 / 06期

关键词：

D O I：

10.1093/jac/dkf045

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：889 / 891

页数：3

共 15 条

[1] Balani SK, 2000, DRUG METAB DISPOS, V28, P1274
[2] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
Bartizal, K
Gill, CJ
Abruzzo, GK
Flattery, AM
Kong, L
Scott, PM
Smith, JG
Leighton, CE
Bouffard, A
Dropinski, JF
Balkovec, J
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2326 - 2332
[3] Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis:: Demonstration of efficacy of caspofungin acetate
Bowman, JC
Abruzzo, GK
Anderson, JW
Flattery, AM
Gill, CJ
Pikounis, VB
Schmatz, DM
Liberator, PA
Douglas, CM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3474 - 3481
[4] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
Espinel-Ingroff, A
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) : 2950 - 2956
[5] The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans
Feldmesser, M
Kress, Y
Mednick, A
Casadevall, A
[J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) : 1791 - 1795
[6] Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice
Ito, M
Nozu, R
Kuramochi, T
Eguchi, N
Suzuki, S
Hioki, K
Itoh, T
Ikeda, F
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2259 - 2262
[7] Efficacy of FK463, a (1,3)-β-D-glucan synthase inhibitor, in disseminated azole-resistant Candida albicans infection in mice
Maesaki, S
Hossain, MA
Miyazaki, Y
Tomono, K
Tashiro, T
Kohno, S
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1728 - 1730
[8] In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species
Moore, CB
Oakley, KL
Denning, DW
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (01) : 11 - 16
[9] In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
Oakley, KL
Moore, CB
Denning, DW
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2726 - 2730
[10] Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia
Petraitiene, R
Petraitis, V
Groll, AH
Sein, T
Schaufele, RL
Francesconi, A
Bacher, J
Avila, NA
Walsh, TJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) : 12 - 23

← 1 2 →